Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-29 Haas Jason Director Grant or award +1,750 1,750
2022-06-29 Haas Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +5,907 5,907
2022-06-10 Sabba Stephen L Director Grant or award +1,004 26,065
2022-06-10 Sabba Stephen L Director Grant or award · Non-Qualified Stock Option (right to buy) −4,340 4,340
2022-06-10 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +5,375 35,769
2022-06-10 FOEHR MATTHEW W President and COO Grant or award +9,137 182,491
2022-06-10 HIGGINS JOHN L Chief Executive Officer Grant or award +20,423 369,016
2022-06-10 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +8,062 52,368
2022-06-10 Aryeh Jason Director Grant or award +1,004 69,668
2022-06-10 Aryeh Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +4,340 4,340
2022-06-10 Boyce Sarah Director Grant or award +1,004 3,896
2022-06-10 Boyce Sarah Director Grant or award · Non-Qualified Stock Option (right to buy) +4,340 4,340
2022-06-10 Cochran Jennifer R. Director Grant or award +1,004 2,165
2022-06-10 Cochran Jennifer R. Director Grant or award · Non-Qualified Stock Option (right to buy) +4,340 4,340
2022-06-10 Davis Todd C Director Grant or award +1,004 51,786
2022-06-10 Davis Todd C Director Grant or award · Non-Qualified Stock Option (right to buy) +4,340 4,340
2022-06-10 Gray Nancy Ryan Director Grant or award +1,004 4,706
2022-06-10 Gray Nancy Ryan Director Grant or award · Non-Qualified Stock Option (right to buy) +4,340 4,340
2022-06-10 KOZARICH JOHN W Director Grant or award +1,004 42,213
2022-06-10 KOZARICH JOHN W Director Grant or award · Non-Qualified Stock Option (right to buy) +4,340 4,340

Page 29 of 43 · 858 trades